These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 5728435)
1. [Pathogenetic relationships between metabolic, immunobiochemical and morphohistochemical factors in rheumatoid arthritis and their diagnostic significance]. Sborowski AB Beitr Rheumatol; 1968; 13():65-72. PubMed ID: 5728435 [No Abstract] [Full Text] [Related]
2. [Metabolic pathogenetic mechanism of rheumatoid arthritis and its therapeutic significance]. Binzus G; Dettmer N; Josenhans G; Tillmann K Z Rheumaforsch; 1972; 31(3):137-52. PubMed ID: 5027030 [No Abstract] [Full Text] [Related]
3. Antibodies to citrullinated proteins in arthritis: pathology and promise. Klareskog L; Widhe M; Hermansson M; Rönnelid J Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522 [TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis and filaggrin. A review. Berthelot JM; Maugars Y; Prost A; Youinou P Rev Rhum Engl Ed; 1995 Feb; 62(2):127-38. PubMed ID: 7600066 [TBL] [Abstract][Full Text] [Related]
5. Treatment of severe rheumatoid arthritis. Lorenzen I Ann Clin Res; 1983 Apr; 15(2):80-7. PubMed ID: 6349514 [TBL] [Abstract][Full Text] [Related]
11. Sex hormones and risks of rheumatoid arthritis and developmental or environmental influences. Masi AT; Aldag JC; Chatterton RT Ann N Y Acad Sci; 2006 Jun; 1069():223-35. PubMed ID: 16855149 [TBL] [Abstract][Full Text] [Related]
12. Animal models of arthritis caused by systemic alteration of the immune system. Sakaguchi S; Sakaguchi N Curr Opin Immunol; 2005 Dec; 17(6):589-94. PubMed ID: 16214319 [TBL] [Abstract][Full Text] [Related]
13. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis. Miyata M; Sato Y; Kasukawa R J Rheumatol; 1999 Jul; 26(7):1436-8. PubMed ID: 10405926 [TBL] [Abstract][Full Text] [Related]
14. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease. Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175 [No Abstract] [Full Text] [Related]
15. Inflammatory cells and bone loss in rheumatoid arthritis. Haynes DR Arthritis Res Ther; 2007; 9(3):104. PubMed ID: 17601357 [TBL] [Abstract][Full Text] [Related]
16. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies]. Emmrich J; Geiler G Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Müller-Ladner U; Pap T; Gay RE; Neidhart M; Gay S Nat Clin Pract Rheumatol; 2005 Dec; 1(2):102-10. PubMed ID: 16932639 [TBL] [Abstract][Full Text] [Related]
19. Animal models of rheumatoid arthritis. Sokoloff L Int Rev Exp Pathol; 1984; 26():107-45. PubMed ID: 6400511 [No Abstract] [Full Text] [Related]
20. Distribution of mast cells in human synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Fritz P; Müller J; Reiser H; Saal JG; Hadam M; Rautenstrauch H; Tuczek HV; Mischlinski A Z Rheumatol; 1984; 43(6):294-8. PubMed ID: 6084372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]